肌松剂对有创机械通气的艾滋病合并肺孢子菌肺炎患者的疗效评价

Effect of muscle relaxant on AIDS patients complicated with pneumocystis pneumonia treated by invasive mechanical ventilation

  • 摘要: 目的 分析肌松剂对有创机械通气艾滋病合并肺孢子菌肺炎患者的疗效。 方法 选取我院2015年1月- 2017年6月收治于ICU的43例艾滋病合并肺孢子菌肺炎患者,根据治疗方法分为治疗组(予肌松剂+常规治疗)22例,对照组(予常规治疗)21例。观察两组治疗前,治疗后6 h、24 h、48 h的氧合指数、气道平台压情况。随访6个月,比较两组治疗后并发症以及生存情况。 结果 治疗组男性18例,平均年龄(43.6±12.4)岁,APACHEⅡ评分(23.2±4.4)分,氧合指数(90.0±12.6) mmHg;对照组男性17例,平均年龄(40.8±10.7)岁,APACHEⅡ评分(24.0±4.0)分,氧合指数(89.7±15.6) mmHg。治疗后,两组氧合指数都呈上升趋势(P=0.000);治疗组氧合指数174.2±44.7) mmHg显著高于对照组(149.8±25.3) mmHg(P=0.000)。治疗组气道平台压(20.7±4.6 cmHg)低于对照组(25.9±5.7) cmHg(P=0.000)。治疗组并发症发生率(14.3%)显著低于对照组(63.6%),治疗组人机对抗(2 vs 8)及气压伤(1 vs 6)的发生例数明显较对照组低(P<0.05),ICU住院期间,两组死亡率差异无统计学意义(P>0.05)。 结论 肌松剂可改善有创机械通气艾滋病合并肺孢子菌肺炎患者的氧合情况和气道压。

     

    Abstract: Objective To analyze the effect of muscle relaxant in the treatment of AIDS complicated with pneumocystis pneumonia in invasive mechanical ventilation. Methods Forty-three AIDS patients with pneumocystis pneumonia in our hospital from January 2015 to June 2017 were divided into treatment group (22 cases, muscle relaxant + routine treatment) and control group (21 cases, routine treatment), according to different treatment methods. The oxygenation index and airway pressure of the two groups were observed before and at 6 hours, 24 hours and 48 hours after treatment. The patients were followed up for 6 months, and the complications and survival of the two groups were compared. Results In the treatment group, there were 18 male patients, with average age of (43.6±12.4) years, the APACHE Ⅱ score was (23.2±4.4) and oxygenation index was (90.0±12.6) mmHg. In the control group, there were 17 male patients with average age of (40.8±10.7) years, and the APACHEⅡ score was (24±4), and the oxygenation index was (89.7±12.4) mmHg. Repeated ANOVA analysis of oxygenation index showed that there was an interaction between time and treatment, the oxygenation index increased by time in two groups (F=17.13, P=0.000), and it increased greater in treatment group than in the control group (F=15.14, P=0.000) (T48, 188.8±37.6 mmHg vs 167.2±20.3 mmHg, P=0.025).Interaction between time and treatment was detected for airway pressure (F=1.46, P=0.024). It decreased over time(F=2.48, P=0.013)and was lower in the treatment group than in the control group (F=49.31, P=0.000) (T48, 21.0±4.5 cmHg vs 24.4±6.3 cmHg, P=0.047). The complication rate in treatment group was significantly lower than the control group (14.3% vs 63.6%). After treatment, there were significant differences in occurrence cases of man-machine confrontation (2 vs 8, P< 0.05) and air pressure injury (1 vs 6, P< 0.05) between two groups, while no statistically significant difference was found in mortality (7 vs 10, P> 0.05) between the two groups during the hospitalization of ICU. Conclusion Muscle relaxant can improve oxygenation and airway pressure in patients with AIDS and pneumocystis pneumonia when invasive mechanical ventilation is applied.

     

/

返回文章
返回